查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球基因组市场研究报告 - 2023 年至 2030 年行业分析、规模、份额、增长、趋势和预测
市场调查报告书
商品编码
1342920

全球基因组市场研究报告 - 2023 年至 2030 年行业分析、规模、份额、增长、趋势和预测

Global Gene Panel Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030
出版日期: | 出版商: Value Market Research | 英文 221 Pages | 商品交期: 最快1-2个工作天内

价格

全球基因检测市场需求预计将从 2022 年的 32.9 亿美元增至 2030 年的近 143.2 亿美元，2023-2030 年研究期间复合年增长率为 20.2%。

基因检测是一种诊断测试，用于在患者表现出可能由多种病症引起的症状或多个基因的变异可能导致可疑病症时缩小诊断范围。基因面板测试可以检查大量基因，这有助于提供癌症信息并提供安全的诊断以防止癌症扩散。基因组用于诊断和治疗，例如癌症风险评估、综合征特异性诊断、疾病渗透和许多其他应用。

市场动态：

导致市场增长的重要因素是慢性病发病率和患病率的上升。此外，诊断服务的技术进步和医疗保健技术的现代化正在推动市场的增长。此外，不断增长的持续研究和开发推动了基因面板市场的发展。此外，男性和女性癌症病例数量的增加以及基因组市场对抗癌症的好处推动了市场增长。然而，高昂的价格和个人对基因报告真实性的严重怀疑是基因面板市场增长的主要製约因素。此外，人们对基因检测潜在益处的认识不断增强，对先进医学检测的需求不断增加，以及对针对性方法和个性化医疗的需求不断增长，是全球基因检测市场增长的主要驱动力。

该研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具还对全球基因组市场的每个细分市场进行了包容性评估。基因面板行业的增长和趋势为这项研究提供了整体方法。

区域分析：

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲基因面板市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。基因组市场的主要参与者包括Illumina, Inc.（美国）、BGI（中国）、Agilent Technologies（美国）、Eurofins Scientific（美国）、QIAGEN（德国）、GENEWIZ, Inc.（美国）、Novogene Corporation（中国） 、Personalis（美国）、Thermo Fisher Scientific（美国）、F. Hoffmann-La Roche AG（瑞士）、Integrated DNA Technologies (IDT)（美国）、GATC Biotech AG（GATC Biotech）（德国）和ArcherDx（我们）。本节包含竞争格局的整体视图，包括各种战略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何定制要求，请写信给我们。我们的研究团队可以根据您的需求提供定制报告。

目录

第一章：前言

  • 报告说明
    • 客观的
    • 目标受众
    • 独特的销售主张 (USP) 和产品
  • 研究范围
  • 研究方法论
    • 市场研究过程
    • 市场研究方法论

第 2 章：执行摘要

  • 市场亮点
  • 全球市场概况

第 3 章：基因面板 - 行业分析

  • 简介 - 市场动态
  • 市场驱动因素
  • 市场限制
  • 机会
  • 行业动态
  • 波特五力分析
  • 市场吸引力分析
    • 按产品和服务分類的市场吸引力分析
    • 按技术分類的市场吸引力分析
    • 设计的市场吸引力分析
    • 市场吸引力分析：按应用分类
    • 最终用户的市场吸引力分析
    • 市场吸引力分析：按地区

第 4 章：价值链分析

  • 价值链分析
  • 原材料分析
    • 原材料清单
    • 原料厂商清单
    • 主要原材料价格走势
  • 潜在买家名单
  • 营销渠道
    • 直效行销
    • 间接营销
    • 营销渠道发展趋势

第 5 章：COVID-19 爆发的影响分析

第 6 章：全球基因组市场分析：按产品和服务分类

  • 按产品和服务分類的概述
  • 历史和预测数据
  • 按产品和服务分析
  • 测试套件
  • 测试服务

第 7 章：全球基因组市场分析：按技术

  • 按技术概述
  • 历史和预测数据
  • 技术分析
  • 基于扩增子的方法
  • 基于杂交的方法

第 8 章：全球基因组市场分析：设计

  • 设计概述
  • 历史和预测数据
  • 设计分析
  • 预先设计的基因面板
  • 定制基因组合

第 9 章：全球基因组市场分析：按应用分类

  • 概述：按应用
  • 历史和预测数据
  • 分析：按应用
  • 癌症风险评估（症候型、高外显率、中高外显率、综合癌症风险、先天性疾病诊断）
  • 药物遗传学
  • 其他应用

第 10 章：全球基因组市场分析：按最终用户分类

  • 最终用户概述
  • 历史和预测数据
  • 最终用户分析
  • 研究及学术机构
  • 医院和诊断实验室
  • 製药和生物技术公司

第 11 章：全球基因组市场分析：按地理位置

  • 顶级公司股票分析
  • 介绍
  • 北美销售分析
    • 概述、历史和预测销售分析
    • 北美按细分市场销售分析
    • 北美按国家/地区销售分析
    • 美国销售分析
    • 加拿大销售分析
    • 墨西哥销售分析
  • 欧洲销售分析
    • 概述、历史和预测销售分析
    • 欧洲按细分市场销售分析
    • 欧洲按国家/地区销售分析
    • 英国销售分析
    • 法国销售分析
    • 德国销售分析
    • 意大利销售分析
    • 俄罗斯销售分析
    • 欧洲其他地区销售分析
  • 亚太地区销售分析
    • 概述、历史和预测销售分析
    • 亚太地区按细分市场销售分析
    • 亚太地区国家/地区销售分析
    • 中国销售分析
    • 印度销售分析
    • 日本销售分析
    • 韩国销售分析
    • 澳大利亚销售分析
    • 亚太地区其他地区销售分析
  • 拉丁美洲销售分析
    • 概述、历史和预测销售分析
    • 拉丁美洲按细分市场销售分析
    • 拉丁美洲按国家/地区销售分析
    • 巴西销售分析
    • 阿根廷销售分析
    • 秘鲁销售分析
    • 智利销售分析
    • 拉丁美洲其他地区销售分析
  • 中东和非洲销售分析
    • 概述、历史和预测销售分析
    • 中东和非洲按细分市场销售分析
    • 中东和非洲国家销售分析
    • 沙特阿拉伯销售分析
    • 阿联酋销售分析
    • 以色列销售分析
    • 南非销售分析
    • 中东其他地区和非洲销售分析

第 12 章：基因面板公司的竞争格局

  • 基因组市场竞争
  • 伙伴关係/协作/协议
  • 併购
  • 新产品发布
  • 其他发展

第 13 章：公司简介

  • 公司股份分析
  • 市场集中度
  • Illumina Inc. (US)
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • BGI (China)
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Agilent Technologies (US)
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Eurofins Scientific (US)
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • QIAGEN (Germany)
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • GENEWIZ Inc. (US)
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Novogene Corporation (China)
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Personalis (US)
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Thermo Fisher Scientific (US)
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • F. Hoffmann-La Roche AG (SwitzerlAnd)
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Integrated DNA Technologies (IDT) (US)
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • GATC Biotech AG (GATC Biotech) (Germany)
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • ArcherDx (US)
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展

注意 - 在公司概况中，财务详细信息和近期发展视情况而定，或者如果是私营公司，则可能不包括在内

Product Code: VMR11219275

The global demand for Gene Panel Market is presumed to reach the market size of nearly USD 14.32 BN by 2030 from USD 3.29 BN in 2022 with a CAGR of 20.2% under the study period 2023 - 2030.

Gene panel is a diagnostic test used to narrow down a diagnosis when the patient shows symptoms that can be caused by a variety of conditions or when variants in multiple genes can cause the suspected condition. Gene panel tests can examine large numbers of genes which helps provide cancer information and provides a secure diagnosis to prevent cancer spread. Gene panel are used in diagnostics and treatments such as cancer risk assessment, syndrome-specific diagnostics, disease penetration, and many other applications.

MARKET DYNAMICS:

The significant factor attributing to the market's growth is the rising incidence and prevalence of chronic diseases. Moreover, increasing technological advancement in diagnostics services and modernization in healthcare techniques are driving the market's growth. Also, the growing ongoing research and development drive the gene panel market. Furthermore, the increasing number of cancer cases in males and females and the benefits of the gene panel market to fight cancer drive market growth. However, high prices and serious doubts among individuals about the authenticity of genetic reports are the major restraints of the gene panel market growth. In addition, growing awareness about the potential benefits of genetic testing, increasing demand for advanced medical testing, and rising demand for targeted approaches and personalized medicine are the primary drivers of the growth of the global gene panel market.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of gene panel. The growth and trends of gene panel industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the gene panel market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product & Service

  • Test Kits
  • Testing Services

By Technique

  • Amplicon-Based Approach
  • Hybridization-Based Approach

By Design

  • Predesigned Gene Panel
  • Customized Gene Panel

By Application

  • Cancer Risk Assessment (Syndrome-Specific, High-Penetrance, High And Moderate-Penetrance, Comprehensive Cancer Risk, Diagnosis Of Congenital Diseases)
  • Pharmacogenetics
  • Other Applications

By End User

  • Research And Academic Institutes
  • Hospital And Diagnostic Laboratories
  • Pharmaceutical And Biotechnology Companies

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Gene Panel market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the gene panel market include Illumina, Inc. (US), BGI (China), Agilent Technologies (US), Eurofins Scientific (US), QIAGEN (Germany), GENEWIZ, Inc. (US), Novogene Corporation (China), Personalis (US), Thermo Fisher Scientific (US), F. Hoffmann-La Roche AG (Switzerland), Integrated DNA Technologies (IDT) (US), GATC Biotech AG (GATC Biotech) (Germany), and ArcherDx (US). This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . GENE PANEL - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product & Service
    • 3.7.2 Market Attractiveness Analysis By Technique
    • 3.7.3 Market Attractiveness Analysis By Design
    • 3.7.4 Market Attractiveness Analysis By Application
    • 3.7.5 Market Attractiveness Analysis By End User
    • 3.7.6 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL GENE PANEL MARKET ANALYSIS BY PRODUCT & SERVICE

  • 6.1 Overview by Product & Service
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Product & Service
  • 6.4 Test Kits Historic and Forecast Sales by Regions
  • 6.5 Testing Services Historic and Forecast Sales by Regions

7 . GLOBAL GENE PANEL MARKET ANALYSIS BY TECHNIQUE

  • 7.1 Overview by Technique
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by Technique
  • 7.4 Amplicon-based Approach Historic and Forecast Sales by Regions
  • 7.5 Hybridization-based Approach Historic and Forecast Sales by Regions

8 . GLOBAL GENE PANEL MARKET ANALYSIS BY DESIGN

  • 8.1 Overview by Design
  • 8.2 Historical and Forecast Data
  • 8.3 Analysis by Design
  • 8.4 Predesigned Gene Panel Historic and Forecast Sales by Regions
  • 8.5 Customized Gene Panel Historic and Forecast Sales by Regions

9 . GLOBAL GENE PANEL MARKET ANALYSIS BY APPLICATION

  • 9.1 Overview by Application
  • 9.2 Historical and Forecast Data
  • 9.3 Analysis by Application
  • 9.4 Cancer Risk Assessment (Syndrome-specific, High-penetrance, High And Moderate-penetrance, Comprehensive Cancer Risk, Diagnosis Of Congenital Diseases) Historic and Forecast Sales by Regions
  • 9.5 Pharmacogenetics Historic and Forecast Sales by Regions
  • 9.6 Other Applications Historic and Forecast Sales by Regions

10 . GLOBAL GENE PANEL MARKET ANALYSIS BY END USER

  • 10.1 Overview by End User
  • 10.2 Historical and Forecast Data
  • 10.3 Analysis by End User
  • 10.4 Research And Academic Institutes Historic and Forecast Sales by Regions
  • 10.5 Hospital And Diagnostic Laboratories Historic and Forecast Sales by Regions
  • 10.6 Pharmaceutical And Biotechnology Companies Historic and Forecast Sales by Regions

11 . GLOBAL GENE PANEL MARKET ANALYSIS BY GEOGRAPHY

  • 11.1. Top Company Share Analysis
  • 11.2. Introduction
  • 11.3. North America Sales Analysis
    • 11.3.1. Overview, Historic and Forecast Sales Analysis
    • 11.3.2. North America By Segment Sales Analysis
    • 11.3.3. North America By Country Sales Analysis
    • 11.3.4. United State Sales Analysis
    • 11.3.5. Canada Sales Analysis
    • 11.3.6. Mexico Sales Analysis
  • 11.4. Europe Sales Analysis
    • 11.4.1. Overview, Historic and Forecast Sales Analysis
    • 11.4.2. Europe by Segment Sales Analysis
    • 11.4.3. Europe by Country Sales Analysis
    • 11.4.4. United Kingdom Sales Analysis
    • 11.4.5. France Sales Analysis
    • 11.4.6. Germany Sales Analysis
    • 11.4.7. Italy Sales Analysis
    • 11.4.8. Russia Sales Analysis
    • 11.4.9. Rest Of Europe Sales Analysis
  • 11.5. Asia Pacific Sales Analysis
    • 11.5.1. Overview, Historic and Forecast Sales Analysis
    • 11.5.2. Asia Pacific by Segment Sales Analysis
    • 11.5.3. Asia Pacific by Country Sales Analysis
    • 11.5.4. China Sales Analysis
    • 11.5.5. India Sales Analysis
    • 11.5.6. Japan Sales Analysis
    • 11.5.7. South Korea Sales Analysis
    • 11.5.8. Australia Sales Analysis
    • 11.5.9. Rest Of Asia Pacific Sales Analysis
  • 11.6. Latin America Sales Analysis
    • 11.6.1. Overview, Historic and Forecast Sales Analysis
    • 11.6.2. Latin America by Segment Sales Analysis
    • 11.6.3. Latin America by Country Sales Analysis
    • 11.6.4. Brazil Sales Analysis
    • 11.6.5. Argentina Sales Analysis
    • 11.6.6. Peru Sales Analysis
    • 11.6.7. Chile Sales Analysis
    • 11.6.8. Rest of Latin America Sales Analysis
  • 11.7. Middle East & Africa Sales Analysis
    • 11.7.1. Overview, Historic and Forecast Sales Analysis
    • 11.7.2. Middle East & Africa by Segment Sales Analysis
    • 11.7.3. Middle East & Africa by Country Sales Analysis
    • 11.7.4. Saudi Arabia Sales Analysis
    • 11.7.5. UAE Sales Analysis
    • 11.7.6. Israel Sales Analysis
    • 11.7.7. South Africa Sales Analysis
    • 11.7.8. Rest Of Middle East And Africa Sales Analysis

12 . COMPETITIVE LANDSCAPE OF THE GENE PANEL COMPANIES

  • 12.1. Gene Panel Market Competition
  • 12.2. Partnership/Collaboration/Agreement
  • 12.3. Merger And Acquisitions
  • 12.4. New Product Launch
  • 12.5. Other Developments

13 . COMPANY PROFILES OF GENE PANEL INDUSTRY

  • 13.1. Company Share Analysis
  • 13.2. Market Concentration Rate
  • 13.3. Illumina Inc. (US)
    • 13.3.1. Company Overview
    • 13.3.2. Company Revenue
    • 13.3.3. Products
    • 13.3.4. Recent Developments
  • 13.4. BGI (China)
    • 13.4.1. Company Overview
    • 13.4.2. Company Revenue
    • 13.4.3. Products
    • 13.4.4. Recent Developments
  • 13.5. Agilent Technologies (US)
    • 13.5.1. Company Overview
    • 13.5.2. Company Revenue
    • 13.5.3. Products
    • 13.5.4. Recent Developments
  • 13.6. Eurofins Scientific (US)
    • 13.6.1. Company Overview
    • 13.6.2. Company Revenue
    • 13.6.3. Products
    • 13.6.4. Recent Developments
  • 13.7. QIAGEN (Germany)
    • 13.7.1. Company Overview
    • 13.7.2. Company Revenue
    • 13.7.3. Products
    • 13.7.4. Recent Developments
  • 13.8. GENEWIZ Inc. (US)
    • 13.8.1. Company Overview
    • 13.8.2. Company Revenue
    • 13.8.3. Products
    • 13.8.4. Recent Developments
  • 13.9. Novogene Corporation (China)
    • 13.9.1. Company Overview
    • 13.9.2. Company Revenue
    • 13.9.3. Products
    • 13.9.4. Recent Developments
  • 13.10. Personalis (US)
    • 13.10.1. Company Overview
    • 13.10.2. Company Revenue
    • 13.10.3. Products
    • 13.10.4. Recent Developments
  • 13.11. Thermo Fisher Scientific (US)
    • 13.11.1. Company Overview
    • 13.11.2. Company Revenue
    • 13.11.3. Products
    • 13.11.4. Recent Developments
  • 13.12. F. Hoffmann-La Roche AG (SwitzerlAnd)
    • 13.12.1. Company Overview
    • 13.12.2. Company Revenue
    • 13.12.3. Products
    • 13.12.4. Recent Developments
  • 13.13. Integrated DNA Technologies (IDT) (US)
    • 13.13.1. Company Overview
    • 13.13.2. Company Revenue
    • 13.13.3. Products
    • 13.13.4. Recent Developments
  • 13.14. GATC Biotech AG (GATC Biotech) (Germany)
    • 13.14.1. Company Overview
    • 13.14.2. Company Revenue
    • 13.14.3. Products
    • 13.14.4. Recent Developments
  • 13.15. ArcherDx (US)
    • 13.15.1. Company Overview
    • 13.15.2. Company Revenue
    • 13.15.3. Products
    • 13.15.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Analysis by Product & Service (USD MN)
  • Test Kits Market Sales by Geography (USD MN)
  • Testing Services Market Sales by Geography (USD MN)
  • Analysis Market by Technique (USD MN)
  • Amplicon-based Approach Market Sales by Geography (USD MN)
  • Hybridization-based Approach Market Sales by Geography (USD MN)
  • Analysis by Design (USD MN)
  • Predesigned Gene Panel Market Sales by Geography (USD MN)
  • Customized Gene Panel Market Sales by Geography (USD MN)
  • Analysis by Application (USD MN)
  • Cancer Risk Assessment (Syndrome-specific, High-penetrance, High And Moderate-penetrance, Comprehensive Cancer Risk, Diagnosis Of Congenital Diseases) Market Sales by Geography (USD MN)
  • Pharmacogenetics Market Sales by Geography (USD MN)
  • Other Applications Market Sales by Geography (USD MN)
  • Analysis by End User (USD MN)
  • Research And Academic Institutes Market Sales by Geography (USD MN)
  • Hospital And Diagnostic Laboratories Market Sales by Geography (USD MN)
  • Pharmaceutical And Biotechnology Companies Market Sales by Geography (USD MN)
  • Global Gene Panel Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Gene Panel Report
  • Market Research Process
  • Market Research Methodology
  • Global Gene Panel Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Product & Service
  • Market Attractiveness Analysis by Technique
  • Market Attractiveness Analysis by Design
  • Market Attractiveness Analysis by Application
  • Market Attractiveness Analysis by End User
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Product & Service (USD MN)
  • Test Kits Market Sales by Geography (USD MN)
  • Testing Services Market Sales by Geography (USD MN)
  • Global Market Analysis by Technique (USD MN)
  • Amplicon-based Approach Market Sales by Geography (USD MN)
  • Hybridization-based Approach Market Sales by Geography (USD MN)
  • Global Market Analysis by Design (USD MN)
  • Predesigned Gene Panel Market Sales by Geography (USD MN)
  • Customized Gene Panel Market Sales by Geography (USD MN)
  • Global Market Analysis by Application (USD MN)
  • Cancer Risk Assessment (Syndrome-specific, High-penetrance, High And Moderate-penetrance, Comprehensive Cancer Risk, Diagnosis Of Congenital Diseases) Market Sales by Geography (USD MN)
  • Pharmacogenetics Market Sales by Geography (USD MN)
  • Other Applications Market Sales by Geography (USD MN)
  • Global Market Analysis by End User (USD MN)
  • Research And Academic Institutes Market Sales by Geography (USD MN)
  • Hospital And Diagnostic Laboratories Market Sales by Geography (USD MN)
  • Pharmaceutical And Biotechnology Companies Market Sales by Geography (USD MN)
  • Global Market by Revenue
  • North America Market by Revenue
  • Europe Market by Revenue
  • Asia Pacific Market by Revenue
  • Latin America Market by Revenue
  • Middle East & Africa Market by Revenue
  • Recent Development in Industry
  • Top Company Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.